Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy (Q33988752)

30 July 2017

title

Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy (English)

1 reference

30 July 2017

1 reference

Michele Rossini

1

1 reference

30 July 2017

Takashi Naito

2

1 reference

30 July 2017

Haichun Yang

3

1 reference

30 July 2017

Michael Freeman

4

1 reference

30 July 2017

Ellen Donnert

5

1 reference

30 July 2017

Li-Jun Ma

6

1 reference

30 July 2017

Stephen R Dunn

7

1 reference

30 July 2017

Kumar Sharma

8

1 reference

30 July 2017

Agnes B Fogo

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

7 January 2010

1 reference

Nephrology Dialysis Transplantation

30 July 2017

published in

1 reference

30 July 2017

volume

25

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

1803-1810

1 reference

describes a project that uses

30 July 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2902889/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Novel therapies of diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Decorin deficiency enhances progressive nephropathy in diabetic mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Sulodexide: a renewed interest in this glycosaminoglycan

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Diabetic kidney disease in thedb/dbmouse

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Review of pharmacodynamics, pharmacokinetics, and therapeutic properites of sulodexide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Vascular permeability and late radiation fibrosis in mouse lung

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Screening for heparin binding variants of antithrombin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

The observation of heparin on endothelium after injection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Therapeutic potential of angiostatin in diabetic nephropathy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Utility of endogenous creatinine clearance as a measure of renal function in mice

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902889

Nephrotic syndrome: molecular and genetic basis

10 December 2018

1 reference

12 December 2020

Evaluation of endothelium-protective effects of drugs in experimental models of endothelial damage

1 reference

12 December 2020

Molecular Profiling of Diabetic Mouse Kidney Reveals Novel Genes Linked to Glomerular Disease

1 reference

12 December 2020

Antiangiogenic therapy in diabetic nephropathy

1 reference

12 December 2020

Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans

1 reference

12 December 2020

Pharmacodynamic Effects of Sulodexide on Profibrinolytic and Haemorrheological Patterns

1 reference

12 December 2020

Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan

1 reference

12 December 2020

A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFP724

1 reference

30 July 2017

1 reference

30 July 2017

1 reference